Fourteen patients receiving routine doses of amitriptyline developed
plasma drug concentrations above 300 ng/ml. Of the 7 patients with plasma
levels above 450 ng/ml, 6 developed a drug-induced delirium as opposed to
none of the 7 with levels below 450 ng/ml. Thus, this adverse effect could
be avoided by monitoring levels and reducing dosage when appropriate.